BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 24335142)

  • 1. Tumor microenvironment-associated modifications of alternative splicing.
    Brosseau JP; Lucier JF; Nwilati H; Thibault P; Garneau D; Gendron D; Durand M; Couture S; Lapointe E; Prinos P; Klinck R; Perreault JP; Chabot B; Abou-Elela S
    RNA; 2014 Feb; 20(2):189-201. PubMed ID: 24335142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative splicing of the multidrug resistance protein 1/ATP binding cassette transporter subfamily gene in ovarian cancer creates functional splice variants and is associated with increased expression of the splicing factors PTB and SRp20.
    He X; Ee PL; Coon JS; Beck WT
    Clin Cancer Res; 2004 Jul; 10(14):4652-60. PubMed ID: 15269137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RBFOX2 is an important regulator of mesenchymal tissue-specific splicing in both normal and cancer tissues.
    Venables JP; Brosseau JP; Gadea G; Klinck R; Prinos P; Beaulieu JF; Lapointe E; Durand M; Thibault P; Tremblay K; Rousset F; Tazi J; Abou Elela S; Chabot B
    Mol Cell Biol; 2013 Jan; 33(2):396-405. PubMed ID: 23149937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pinin interacts with C-terminal binding proteins for RNA alternative splicing and epithelial cell identity of human ovarian cancer cells.
    Zhang Y; Kwok JS; Choi PW; Liu M; Yang J; Singh M; Ng SK; Welch WR; Muto MG; Tsui SK; Sugrue SP; Berkowitz RS; Ng SW
    Oncotarget; 2016 Mar; 7(10):11397-411. PubMed ID: 26871283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation and functional significance of CDC42 alternative splicing in ovarian cancer.
    He X; Yuan C; Yang J
    Oncotarget; 2015 Oct; 6(30):29651-63. PubMed ID: 26336992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quaking I controls a unique cytoplasmic pathway that regulates alternative splicing of myelin-associated glycoprotein.
    Zhao L; Mandler MD; Yi H; Feng Y
    Proc Natl Acad Sci U S A; 2010 Nov; 107(44):19061-6. PubMed ID: 20956316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-canonical splice junction processing increases the diversity of RBFOX2 splicing isoforms.
    Choi S; Cho N; Kim KK
    Int J Biochem Cell Biol; 2022 Mar; 144():106172. PubMed ID: 35124219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long non-coding RNA MALAT1 promotes ovarian cancer progression by regulating RBFOX2-mediated alternative splicing.
    Gordon MA; Babbs B; Cochrane DR; Bitler BG; Richer JK
    Mol Carcinog; 2019 Feb; 58(2):196-205. PubMed ID: 30294913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RON alternative splicing regulation in primary ovarian cancer.
    Mayer S; Hirschfeld M; Jaeger M; Pies S; Iborra S; Erbes T; Stickeler E
    Oncol Rep; 2015 Jul; 34(1):423-30. PubMed ID: 25997828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple alternative splicing markers for ovarian cancer.
    Klinck R; Bramard A; Inkel L; Dufresne-Martin G; Gervais-Bird J; Madden R; Paquet ER; Koh C; Venables JP; Prinos P; Jilaveanu-Pelmus M; Wellinger R; Rancourt C; Chabot B; Abou Elela S
    Cancer Res; 2008 Feb; 68(3):657-63. PubMed ID: 18245464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RBFOX2 deregulation promotes pancreatic cancer progression and metastasis through alternative splicing.
    Maurin M; Ranjouri M; Megino-Luque C; Newberg JY; Du D; Martin K; Miner RE; Prater MS; Wee DKB; Centeno B; Pruett-Miller SM; Stewart P; Fleming JB; Yu X; Bravo-Cordero JJ; Guccione E; Black MA; Mann KM
    Nat Commun; 2023 Dec; 14(1):8444. PubMed ID: 38114498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of splicing factors in human ovarian cancer.
    Fischer DC; Noack K; Runnebaum IB; Watermann DO; Kieback DG; Stamm S; Stickeler E
    Oncol Rep; 2004 May; 11(5):1085-90. PubMed ID: 15069551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rbfox2-coordinated alternative splicing of Mef2d and Rock2 controls myoblast fusion during myogenesis.
    Singh RK; Xia Z; Bland CS; Kalsotra A; Scavuzzo MA; Curk T; Ule J; Li W; Cooper TA
    Mol Cell; 2014 Aug; 55(4):592-603. PubMed ID: 25087874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RBFOX2 alters splicing outcome in distinct binding modes with multiple protein partners.
    Zhou D; Couture S; Scott MS; Abou Elela S
    Nucleic Acids Res; 2021 Aug; 49(14):8370-8383. PubMed ID: 34244793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Snail Driving Alternative Splicing of CD44 by ESRP1 Enhances Invasion and Migration in Epithelial Ovarian Cancer.
    Chen L; Yao Y; Sun L; Zhou J; Miao M; Luo S; Deng G; Li J; Wang J; Tang J
    Cell Physiol Biochem; 2017; 43(6):2489-2504. PubMed ID: 29131012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The RNA-binding protein Rbfox2: an essential regulator of EMT-driven alternative splicing and a mediator of cellular invasion.
    Braeutigam C; Rago L; Rolke A; Waldmeier L; Christofori G; Winter J
    Oncogene; 2014 Feb; 33(9):1082-92. PubMed ID: 23435423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in expression pattern of splicing factors in epithelial ovarian cancer and its clinical impact.
    Iborra S; Hirschfeld M; Jaeger M; Zur Hausen A; Braicu I; Sehouli J; Gitsch G; Stickeler E
    Int J Gynecol Cancer; 2013 Jul; 23(6):990-6. PubMed ID: 23748175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of p73 splice variants and protein in benign and malignant ovarian tumours.
    Zwahlen D; Tschan MP; Grob TJ; Peters UR; Fink D; Haenggi W; Altermatt HJ; Cajot JF; Tobler A; Fey MF; Aebi S
    Int J Cancer; 2000 Oct; 88(1):66-70. PubMed ID: 10962441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative isoform regulation in human tissue transcriptomes.
    Wang ET; Sandberg R; Luo S; Khrebtukova I; Zhang L; Mayr C; Kingsmore SF; Schroth GP; Burge CB
    Nature; 2008 Nov; 456(7221):470-6. PubMed ID: 18978772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QKI-5 regulates the alternative splicing of cytoskeletal gene ADD3 in lung cancer.
    Wang JZ; Fu X; Fang Z; Liu H; Zong FY; Zhu H; Yu YF; Zhang XY; Wang SF; Huang Y; Hui J
    J Mol Cell Biol; 2021 Aug; 13(5):347-360. PubMed ID: 33196842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.